Table 2.
Association between symptoms and four questionnaire score in all participants
| Symptoms | ISI (cutoff = 15) | PHQ-9 (cutoff = 10) | GAD-7 (cutoff = 10) | PSQI (cutoff = 5) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 15 N = 241 |
≥ 15 N = 131 |
P value | < 10 N = 204 |
≥ 10 N = 168 |
P value | < 10 N = 239 |
≥ 10 N = 133 |
P value | < 5 N = 80 |
≥ 5 N = 292 |
P value | |
| Fever | 32 (13.3%) | 25 (19.1%) | 0.185 | 20 (9.8%) | 37 (22%) | 0.004 | 30 (12.6%) | 27 (20.3%) | 0.087 | 10 (12.5%) | 47 (16.1%) | 0.297 |
| Chills | 63 (26.1%) | 58 (44.3%) | 0.002 | 44 (21.6%) | 77 (45.8%) | < 0.001 | 61 (25.5%) | 60 (45.1%) | 0.004 | 15 (18.8%) | 106 (36.3%) | 0.006 |
| Cough | 78 (32.4%) | 64 (48.9%) | 0.007 | 60 (29.4%) | 82 (48.8%) | 0.003 | 77 (32.2%) | 65 (48.9%) | 0.013 | 25 (31.3%) | 117 (40.1%) | 0.258 |
| Dyspnea | 73 (30.3%) | 62 (47.3%) | 0.004 | 53 (26%) | 82 (48.8%) | < 0.001 | 69 (28.9%) | 66 (49.6%) | 0.001 | 20 (25%) | 115 (39.4%) | 0.010 |
| Nausea | 36 (14.9%) | 41 (31.3%) | 0.001 | 23 (11.3%) | 54 (32.1%) | < 0.001 | 31 (13%) | 46 (34.6%) | 0.002 | 10 (12.5%) | 67 (22.9%) | 0.121 |
| Diarrhea | 30 (12.4%) | 50 (38.2%) | < 0.001 | 19 (9.3%) | 61 (36.3%) | < 0.001 | 32 (13.4%) | 48 (36.1%) | < 0.001 | 9 (11.3%) | 71 (24.3%) | 0.043 |
| Anorexia | 52 (21.6%) | 48 (36.6%) | 0.003 | 35 (17.2%) | 65 (38.7%) | < 0.001 | 53 (22.2%) | 47 (35.3%) | 0.026 | 11 (13.8%) | 89 (30.5%) | 0.004 |
| Abdominal pain | 36 (14.9%) | 49 (37.4%) | < 0.001 | 31 (15.2%) | 54 (32.1%) | 0.001 | 39 (16.3%) | 46 (34.6%) | 0.001 | 9 (11.3%) | 76 (26%) | 0.044 |
| Rhinorrhea | 55 (22.8%) | 41 (31.3%) | 0.225 | 39 (19.1%) | 57 (33.9%) | 0.014 | 51 (21.3%) | 45 (33.8%) | 0.074 | 13 (16.3%) | 83 (28.4%) | 0.039 |
| Nasal congestion | 46 (19.1%) | 40 (30.5%) | 0.032 | 34 (16.7%) | 52 (31%) | 0.003 | 44 (18.4%) | 42 (31.6%) | 0.003 | 9 (11.3%) | 77 (26.4%) | 0.006 |
| Anosmia | 21 (8.7%) | 23 (17.6%) | 0.006 | 14 (6.9%) | 30 (17.9%) | 0.001 | 19 (7.9%) | 25 (18.8%) | 0.007 | 6 (7.5%) | 38 (13%) | 0.190 |
| Weight loss | 22 (9.1%) | 21 (16%) | 0.143 | 12 (5.9%) | 31 (18.5%) | < 0.001 | 18 (7.5%) | 25 (18.8%) | 0.007 | 6 (7.5%) | 37 (12.7%) | 0.201 |
| Chest pain | 54 (22.4%) | 46 (35.1%) | 0.026 | 38 (18.6%) | 62 (36.9%) | < 0.001 | 55 (23%) | 45 (33.8%) | 0.065 | 8 (10%) | 92 (31.5%) | < 0.001 |
| Myalgia | 63 (26.1%) | 72 (55%) | < 0.001 | 46 (22.5%) | 89 (53%) | < 0.001 | 64 (26.8%) | 71 (53.4%) | < 0.001 | 17 (21.3%) | 118 (40.4%) | 0.001 |
| Fatigue | 103 (42.7%) | 96 (73.3%) | < 0.001 | 77 (37.7%) | 122 (72.6%) | < 0.001 | 98 (41%) | 101 (75.9%) | < 0.001 | 27 (33.8%) | 172 (58.9%) | 0.001 |
| positive Corona-virus RT-PCR | 21 (8.7%) | 14 (10.7%) | 0.869 | 13 (6.4%) | 22 (13.1%) | 0.134 | 15 (6.27%) | 20 (15.0%) | 0.027 | 4 (5%) | 31 (10.6%) | 0.178 |
P values < 0.05 are statistically significant
P values are based on the Cochran-Mantel-Haenszel test were confounded by age and sex
ISI Insomnia Severity Index, PHQ-9 Patient’s Health Questionnaire-9, GAD-7 Generalized Anxiety Disorder-7, PSQI Pittsburgh’s Sleep Quality Index